Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-label, Randomized Study to Evaluate the Long Term Effectiveness of Levetiracetam as Monotherapy in Comparison With Oxcarbazepine in Subjects With Newly or Recently Diagnosed Partial Epilepsy

NCT01498822 is registered in ClinicalTrials.gov with Korea UCB Co., Ltd. as lead sponsor.

NCT NCT01498822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01498822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-label, Randomized Study to Evaluate the Long Term Effectiveness of Levetiracetam as Monotherapy in Comparison With Oxcarbazepine in Subjects With Newly or Recently Diagnosed Partial Epilepsy
Lead sponsor
Korea UCB Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2011
Completion date
July 31, 2014
Enrollment
353 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy